Advertisement
SKIP ADVERTISEMENT
You have a preview view of this article while we are checking your access. When we have confirmed access, the full article content will load.
Doctors agree that more needs to be done to address childhood obesity, but are divided over the use of powerful GLP-1 drugs.
Credit... Vartika Sharma
Nov. 16, 2026 Updated 12:34 p.m. ET
New results from a closely watched clinical trial showed that weight-loss drugs are effective for children as young as 6, though some doctors say they are concerned about the prospect of prescribing these medications to such young patients.
The study, presented Monday at the medical conference Obesity Week, examined children ages 6 to 11 who were taking semaglutide, the compound in Ozempic and Wegovy. Most children in the trial had severe obesity, meaning they had a body mass index of 35 or higher.…